Aurobindo Pharma shares decline as FDA issues warning letter to key subsidiary despite strong quarterly results

Shares of Aurobindo Pharma fell following the US FDA’s warning to its subsidiary Eugia Pharma Specialities, though the company reports robust quarterly profits and maintains current US shipments remain unaffected. Aurobindo Pharma shares fell after the company disclosed that the…













